Tradestie Institutional Equity Comparison Engine

PHYL vs BDCZ โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-20 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

PHYL Overall Edge

PHYL Captures Institutional Edge (1โ€“0 Pillars ยท 1โ€“2 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to PGIM Active High Yield Bond ETF (PHYL) driven by superior Momentum & Technical. Fundamentally, PHYL trades at N/M Forward P/E with N/A operating margin (N/A YoY revenue) versus BDCZ at N/M Forward P/E and N/A operating margin (N/A YoY). In options structure, PHYL sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against BDCZ sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner Tie
PHYL N/M vs BDCZ N/M Fwd P/E
Growth & Margin Winner Tie
Op Margin N/A vs N/A ยท YoY N/A vs N/A
Momentum & Technical Winner PHYL
1Y -5.7% vs -14.9% ยท 52W Pos 1% vs 18%
Options & Structure Winner Tie
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (N/A IV)
PHYL NYSE Arca
PGIM Active High Yield Bond ETF
Institutional Equity
$33.20
-0.18% 1D
Market Cap N/A
1M Return -1.07%
1Y Return -5.7%
Forward P/E N/M
Unified AI Score
42.3 / 100 HOLD
Tech 31.0 Fund 50.0 Flow 50.0 Mom 74.0
BDCZ NYSE Arca
ETRACS MarketVector Business Development Companies Liquid Index ETN due April 26, 2041
Institutional Equity
$13.70
-1.14% 1D
Market Cap N/A
1M Return -0.18%
1Y Return -14.86%
Forward P/E N/M
Unified AI Score
48.1 / 100 HOLD
Tech 40.0 Fund 50.0 Flow 50.0 Mom 70.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: PHYL -5.7% BDCZ -14.86% Spread: +9.1 pp (PHYL Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
PHYL TTM Op. Margin: N/A BDCZ TTM Op. Margin: N/A
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on PHYL vs BDCZ. Trailing 12-month operating profitability (PHYL N/A vs BDCZ N/A) and valuation multiples (PHYL N/M vs BDCZ N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: PHYL (1) vs BDCZ (2)
Institutional Metric PHYL BDCZ Criterion Row Winner
Market Capitalization Scale N/A N/A Larger Scale Tie
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth N/A N/A Higher Growth Tie
Operating Margin (TTM) Profitability N/A N/A Higher Margin Tie
Net Profit Margin Profitability N/A N/A Higher Margin Tie
Return on Equity (ROE) Capital Efficiency N/A N/A Higher ROE Tie
52-Week Range Position Momentum 1% ($33โ€“$36) 18% ($13โ€“$17) Stronger Trend BDCZ
Beta / 30D Volatility Risk Regime 0.17ฮฒ ยท 5% Vol 0.41ฮฒ ยท 20% Vol Lower Realized Risk PHYL
Unified Institutional Score Composite Signal 42.3 / 100 (HOLD) 48.1 / 100 (HOLD) Higher Composite BDCZ

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full PHYL vs BDCZ Buy Guide
PHYL UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live PHYL Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
BDCZ UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live BDCZ Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither PHYL nor BDCZ registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.